11/12/2024
9:40 AM | FMR LLC (Filed by)
Xenon Pharmaceuticals (Subject)
| Form SC 13G/A | |
08/08/2024
3:36 PM | Xenon Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/12/2024
8:44 PM | PIMSTONE SIMON N. (Reporting)
Xenon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2024
4:32 PM | ROBIN SHERRINGTON (Reporting)
Xenon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024
4:42 PM | GANNON STEVEN (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
4:42 PM | GAROFALO ELIZABETH A. (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
4:42 PM | Gover Justin D. (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
06/05/2024
4:42 PM | Machado Patrick (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
4:43 PM | PATOU GARY (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
4:41 PM | Svoronos Dawn (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
4:41 PM | Cannon Gillian (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
4:30 PM | PIMSTONE SIMON N. (Reporting)
Xenon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024
3:22 PM | Xenon Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/05/2024
3:12 PM | Xenon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
3:09 PM | Xenon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
3:26 PM | Xenon Pharmaceuticals (Filer)
| Form DEF 14A | |
04/19/2024
3:21 PM | Xenon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
5:41 PM | AULIN SHERRY (Reporting)
Xenon Pharmaceuticals (Issuer)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
5:42 PM | Von Seggern Christopher (Reporting)
Xenon Pharmaceuticals (Issuer)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
5:33 PM | MORTIMER IAN (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
5:34 PM | DiFabio Andrea (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
5:35 PM | ROBIN SHERRINGTON (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
5:37 PM | EMPFIELD JAMES R. (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
5:38 PM | KENNEY CHRISTOPHER JOHN (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:09 PM | GAROFALO ELIZABETH A. (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
5:47 PM | GAROFALO ELIZABETH A. (Reporting)
Xenon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
4:27 PM | Xenon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/08/2024
4:28 PM | GANNON STEVEN (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:31 PM | ROBIN SHERRINGTON (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
6:03 PM | GANNON STEVEN (Reporting)
Xenon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
6:04 PM | ROBIN SHERRINGTON (Reporting)
Xenon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
3:36 PM | Xenon Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/29/2024
3:10 PM | Xenon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
8:12 AM | Avoro Capital Advisors LLC (Filed by)
Xenon Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024
6:43 AM | DRIEHAUS CAPITAL MANAGEMENT LLC (Filed by)
Xenon Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/09/2024
9:05 AM | FMR LLC (Filed by)
Xenon Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/02/2024
3:41 PM | ROBIN SHERRINGTON (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
4:04 PM | AZAB MOHAMMAD (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
8:50 PM | PATOU GARY (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4/A | |
12/15/2023
4:38 PM | PATOU GARY (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
7:02 PM | PATOU GARY (Reporting)
Xenon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad) As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential.
Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention. 👉 Click here to access your FREE report now! |
11/29/2023
4:05 PM | Xenon Pharmaceuticals (Filer)
| Form 424B5 | |
11/27/2023
6:03 AM | Xenon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free XENE Stock Alerts